Literature DB >> 16936806

Lactoferrin downregulates pro-inflammatory cytokines upexpressed in intestinal epithelial cells infected with invasive or noninvasive Escherichia coli strains.

Francesca Berlutti1, Serena Schippa, Clara Morea, Serena Sarli, Brunella Perfetto, Giovanna Donnarumma, Piera Valenti.   

Abstract

Intestinal epithelial cells are able to differentially interact with commensal or pathogenic microorganisms, triggering a physiological or destructive inflammation, respectively. To mimic commensal-enteroinvasive bacteria-host cell interaction, we infected Caco-2 cells with noninvasive Escherichia coli HB101 and with recombinant invasive E. coli HB101(pRI203). Using DNA microarray mRNA profiling and ELISA assays, we studied the expression of several cytokine and cytokine-related genes in infected Caco-2 cells in the absence or presence of bovine lactoferrin (bLf). Infection of Caco-2 cells with the noninvasive strain induced a slight increase in the expression of interleukin 8 (IL-8), whereas infection with invasive E. coli HB101(pRI203) induced a significant increase in the expression of IL-8 as well as other pro-inflammatory cytokines. The addition of bLf, in native- or holo-form, did not influence expression of cytokine genes by uninfected Caco-2 cells, but it decreased expression of IL-8 by cells infected with E.coli HB101. Moreover, except for IL-8, bLfs dramatically downregulated pro-inflammatory cytokines upexpressed by Caco-2 cells infected with the invasive strain. Although IL-8 was decreased by bLfs, it remained upregulated, suggesting that it could be a signal of persistence of intracellular bacteria. The bLf ability to reduce expression of some pro-inflammatory cytokines, which appears independent of its iron saturation, might represent an important natural mechanism in regulating epithelial cell responses to pathogenic bacteria and in limiting cell damage and the spread of infections.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16936806     DOI: 10.1139/o06-039

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  20 in total

Review 1.  Lactoferrin and prematurity: a promising milk protein?

Authors:  Theresa J Ochoa; Stéphane V Sizonenko
Journal:  Biochem Cell Biol       Date:  2016-10-26       Impact factor: 3.626

2.  Randomized controlled trial of lactoferrin for prevention of sepsis in peruvian neonates less than 2500 g.

Authors:  Theresa J Ochoa; Jaime Zegarra; Luis Cam; Raul Llanos; Alonso Pezo; Karen Cruz; Alonso Zea-Vera; Cesar Cárcamo; Miguel Campos; Sicilia Bellomo
Journal:  Pediatr Infect Dis J       Date:  2015-06       Impact factor: 2.129

3.  Lactoferrin and oral diseases: current status and perspective in periodontitis.

Authors:  Francesca Berlutti; Andrea Pilloni; Miriam Pietropaoli; Antonella Polimeni; Piera Valenti
Journal:  Ann Stomatol (Roma)       Date:  2012-01-27

4.  Lactoferrin CpG Island Hypermethylation and Decoupling of mRNA and Protein Expression in the Early Stages of Prostate Carcinogenesis.

Authors:  Corey M Porter; Michael C Haffner; Ibrahim Kulac; Janielle P Maynard; Javier A Baena-Del Valle; William B Isaacs; Srinivasan Yegnasubramanian; Angelo M De Marzo; Karen S Sfanos
Journal:  Am J Pathol       Date:  2019-09-06       Impact factor: 4.307

Review 5.  Body iron delocalization: the serious drawback in iron disorders in both developing and developed countries.

Authors:  R Paesano; T Natalizi; F Berlutti; P Valenti
Journal:  Pathog Glob Health       Date:  2012-08       Impact factor: 2.894

Review 6.  Antimicrobial peptides and colitis.

Authors:  Samantha Ho; Charalabos Pothoulakis; Hon Wai Koon
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

7.  Lactoferrin Adsorbed onto Biomimetic Hydroxyapatite Nanocrystals Controlling - In Vivo - the Helicobacter pylori Infection.

Authors:  Andrea Fulgione; Nunzia Nocerino; Marco Iannaccone; Sante Roperto; Federico Capuano; Norberto Roveri; Marco Lelli; Antonio Crasto; Armando Calogero; Argenia Paola Pilloni; Rosanna Capparelli
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

Review 8.  Trichomoniasis and lactoferrin: future prospects.

Authors:  Rakesh Sehgal; Kapil Goyal; Alka Sehgal
Journal:  Infect Dis Obstet Gynecol       Date:  2012-09-04

9.  Oropharyngeal administration of mother's colostrum, health outcomes of premature infants: study protocol for a randomized controlled trial.

Authors:  Nancy A Rodriguez; Maximo Vento; Erika C Claud; Chihsiung E Wang; Michael S Caplan
Journal:  Trials       Date:  2015-10-12       Impact factor: 2.279

10.  The impact of lactoferrin with different levels of metal saturation on the intestinal epithelial barrier function and mucosal inflammation.

Authors:  Grzegorz Majka; Grażyna Więcek; Małgorzata Śróttek; Klaudyna Śpiewak; Małgorzata Brindell; Joanna Koziel; Janusz Marcinkiewicz; Magdalena Strus
Journal:  Biometals       Date:  2016-10-18       Impact factor: 2.949

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.